Submission Details
| 510(k) Number | K013912 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 2001 |
| Decision Date | January 18, 2002 |
| Days to Decision | 52 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K013912 is an FDA 510(k) clearance for the CREATINE KINASE (CK-NAC), a Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (Class II — Special Controls, product code CGS), submitted by Jas Diagnostics, Inc. (Miami, US). The FDA issued a Cleared decision on January 18, 2002, 52 days after receiving the submission on November 27, 2001. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K013912 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 27, 2001 |
| Decision Date | January 18, 2002 |
| Days to Decision | 52 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CGS — Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1215 |